Board of Directors: Vice-President (elected 2013, [TT2014-TT2017, TT2017-TT2020])

Max-Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany

Benoît Kanzler, Ph.D, is leading the Transgenic Mouse Core Facility (TMCF) at the Max-Planck Institute of Immunobiology and Epigenetics in Freiburg, Germany. He has been the Vice-President of the International Society for Transgenic Technologies since 2013.

His fascination for science, developmental biology and transgenic technologies arose from his graduate and post-doctoral studies of the molecular mechanisms involved in the development of the vertebrate body. He was particularly intrigued by the fascinating molecular mechanisms governing Hox genes spatio-temporal regulation during the genesis of complex embryonic axial structures, such as the integument or the middle ear. Since 1998, when he had to generate himself his first series of transgenic embryos, he gained a broad experience and knowledge in generating and designing transgenic and state-of-the-art gene-targeted animal models for the research community.

He has been active in efforts to promote the ISTT by participating in Transgenic Technology meetings since the 5th meeting in Uppsala (TT2004, Sweden). Since TT2010 in Berlin, and more recently in his position of Vice-President and as chair of the TT Meeting Analysis, Oversight and Support Committee, he has been actively involved in the preparation and organization of the TT Meetings in Guangzhou, Edinburgh, Prague and Salt Lake City.